Not all individuals with CLL need therapy. Despite all new advancements, the iwCLL continue to suggests watchful observation for sufferers with asymptomatic illness.86 This recommendation is predicated on at least two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Both of those trials concluded https://greatk655fzq7.wikicommunication.com/user